Funded by the NIH HEAL Initiative℠
This project will develop models to predict individual patient’s risk for relapse (or dropout from treatment) when treated with medications for OUD including methadone, buprenorphine, or extended-release depot naltrexone.
CTN Protocol ID:
Sean Luo, MD, Ph.D.
Department of Psychiatry
1051 Riverside Drive, Unit 66
New York, NY 10033
Daniel J. Feaster, Ph.D.
Associate Professor, Senior Biostatician
University of Miami Miller School of Medicine
Center for Family Studies
1120 NW 14th Street, Suite 1059
Miami, FL 33136